201004-46-8
201004-46-8
Chemical Structure
Fmoc-Lys(Palmitoyl)-OH
- CAS No.: 201004-46-8
- Formula:C37H54N2O5
- Molecular Weight:606.84
IUPAC Name: N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N6-palmitoyl-L-lysine
InChIKey: DQZCUQJUXKWZEE-UMSFTDKQSA-N
SMILES: O=C(O)[C@H](CCCCNC(CCCCCCCCCCCCCCC)=O)NC(OCC1C2=C(C3=C1C=CC=C3)C=CC=C2)=O
Biological Activity: Fmoc-Lys(Palmitoyl)-OH is a Fmoc-amino acid with long alkyl chains. Fmoc-Lys(Palmitoyl)-OH can be used for peptide synthesis[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Fmoc-Lys(Palmitoyl)-OH | 98.90% | Fmoc-Lys(Palmitoyl)-OH is a Fmoc-amino acid with long alkyl chains. Fmoc-Lys(Palmitoyl)-OH can be used for peptide synthesis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-L-Lys(N3-Gly)-OH | 98.25% | Fmoc-L-Lys(N3-Gly)-OH is a click chemistry reagent containing a lysine-containing azidoacetyl group building-block for SPPS and can be used for various biochemical studies. It contains an azide group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing alkyne groups. It can also undergo ring strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing DBCO or BCN groups. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-L-Lys(Pryoc)-OH | Fmoc-L-Lys(Pryoc)-OH (N2-Fmoc-N6-[(propargyloxy)carbonyl]-L-lysine) is a click chemistry reagent containing an azide group. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-D-Lys(pentynoyl)-OH | Fmoc-D-Lys(pentynoyl)-OH is a click chemistry reagent containing an azide group. Used to introduce alkyne functionality into peptides that can be further modified using Click-chemistry. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-Lys[Octa(OtBu)-Glu-OtBu]-OH | Fmoc-Lys[Octa(OtBu)-Glu-OtBu]-OH is an Fmoc-protected amino acid derivative. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-Lys(Ac)-OH | 99.79% | Fmoc-Lys(Ac)-OH is a lysine derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-Lys(Pal-Glu-OtBu)-OH | 99.93% | Fmoc-Lys(Pal-Glu-OtBu)-OH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Lys(Pal-Glu-OtBu)-OH is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-12-aminododecanoic acid | 98.99% | Fmoc-12-aminododecanoic acid is an alkane chain with terminal Fmoc-protected amine and carboxylic acid groups. The compound can be used as a PROTAC linker in the synthesis of PROTACs. The Fmoc group can be deprotected under basic condition to obtain the free amine which can be used for further conjugations. The terminal carboxylic acid can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-hLys(Boc)-OH | 99.52% | Fmoc-hLys(Boc)-OH is a lysine derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
14-(Fmoc-amino)-tetradecanoic acid | 14-(Fmoc-amino)-tetradecanoic acid can be used as a PROTAC linker in the synthesis of PROTACs. 14-(Fmoc-amino)-tetradecanoic acid is an alkane chain with terminal Fmoc-protected amine and carboxylic acid groups. The Fmoc group can be deprotected under basic condition to obtain the free amine which can be used for further conjugations. The terminal carboxylic acid can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
16-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]hexadecanoic acid | 16-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]hexadecanoic acid is a PROTAC linker that can be used in the synthesis of PROTACs. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
